Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20388540rdf:typepubmed:Citationlld:pubmed
pubmed-article:20388540lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:20388540lifeskim:mentionsumls-concept:C0023473lld:lifeskim
pubmed-article:20388540lifeskim:mentionsumls-concept:C0040648lld:lifeskim
pubmed-article:20388540lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:20388540lifeskim:mentionsumls-concept:C0308269lld:lifeskim
pubmed-article:20388540lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:20388540lifeskim:mentionsumls-concept:C0324024lld:lifeskim
pubmed-article:20388540pubmed:issue8lld:pubmed
pubmed-article:20388540pubmed:dateCreated2010-5-24lld:pubmed
pubmed-article:20388540pubmed:abstractTextSlug, a Snail-related zinc-finger transcription factor implicated in the increased motility of mesenchymal cells during embryonic development and progression of cancer cells towards an invasive phenotype, plays a specific and critical role in the pathogenesis of Bcr-Abl-associated leukemias. Here we report that Slug over-expression associated with Bcr-Abl is conditional upon the tyrosine kinase (TK) activity of 210 fusion protein. Slug over-expression is driven by transcriptional events eventually integrated by post-transcriptional mechanisms leading to protein stabilization and is at least partly regulated by the ERK1/2 mitogen-activated protein kinase (MAPK). It contributes to apoptosis resistance of leukemic progenitors through the repression of pro-apoptotic Puma. Moreover, Slug is a component of leukemic progenitor resistance to imatinib mesylate (IM) driven by Bcr-Abl point mutations and, in particular, by T315I. Slug over-expression associated with p210 Bcr-Abl TK either in the wild type (wt) or mutated conformation results in a significant reduction of E-cadherin, the substrate of Beta catenin at cell membranes. In conclusion, our results suggest that Slug has a central role in a complex network involved in prolonged survival and IM resistance of CML progenitors.lld:pubmed
pubmed-article:20388540pubmed:languageenglld:pubmed
pubmed-article:20388540pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20388540pubmed:citationSubsetIMlld:pubmed
pubmed-article:20388540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20388540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20388540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20388540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20388540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20388540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20388540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20388540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20388540pubmed:statusMEDLINElld:pubmed
pubmed-article:20388540pubmed:monthAuglld:pubmed
pubmed-article:20388540pubmed:issn1873-3913lld:pubmed
pubmed-article:20388540pubmed:authorpubmed-author:BarbieriEnzaElld:pubmed
pubmed-article:20388540pubmed:authorpubmed-author:SantucciMaria...lld:pubmed
pubmed-article:20388540pubmed:authorpubmed-author:ManciniManuel...lld:pubmed
pubmed-article:20388540pubmed:authorpubmed-author:IacobucciIlar...lld:pubmed
pubmed-article:20388540pubmed:authorpubmed-author:SalvestriniVa...lld:pubmed
pubmed-article:20388540pubmed:authorpubmed-author:PettaSaraSlld:pubmed
pubmed-article:20388540pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20388540pubmed:volume22lld:pubmed
pubmed-article:20388540pubmed:ownerNLMlld:pubmed
pubmed-article:20388540pubmed:authorsCompleteYlld:pubmed
pubmed-article:20388540pubmed:pagination1247-53lld:pubmed
pubmed-article:20388540pubmed:meshHeadingpubmed-meshheading:20388540...lld:pubmed
pubmed-article:20388540pubmed:meshHeadingpubmed-meshheading:20388540...lld:pubmed
pubmed-article:20388540pubmed:meshHeadingpubmed-meshheading:20388540...lld:pubmed
pubmed-article:20388540pubmed:meshHeadingpubmed-meshheading:20388540...lld:pubmed
pubmed-article:20388540pubmed:meshHeadingpubmed-meshheading:20388540...lld:pubmed
pubmed-article:20388540pubmed:meshHeadingpubmed-meshheading:20388540...lld:pubmed
pubmed-article:20388540pubmed:meshHeadingpubmed-meshheading:20388540...lld:pubmed
pubmed-article:20388540pubmed:meshHeadingpubmed-meshheading:20388540...lld:pubmed
pubmed-article:20388540pubmed:meshHeadingpubmed-meshheading:20388540...lld:pubmed
pubmed-article:20388540pubmed:meshHeadingpubmed-meshheading:20388540...lld:pubmed
pubmed-article:20388540pubmed:meshHeadingpubmed-meshheading:20388540...lld:pubmed
pubmed-article:20388540pubmed:meshHeadingpubmed-meshheading:20388540...lld:pubmed
pubmed-article:20388540pubmed:meshHeadingpubmed-meshheading:20388540...lld:pubmed
pubmed-article:20388540pubmed:year2010lld:pubmed
pubmed-article:20388540pubmed:articleTitleZinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells.lld:pubmed
pubmed-article:20388540pubmed:affiliationDepartment of Hematology and Oncology Lorenzo e Ariosto Seràgnoli, University of Bologna-Medical School, Via Massarenti 9, 40138-Bologna, Italy. mancini_manu@yahoo.com <mancini_manu@yahoo.com>lld:pubmed
pubmed-article:20388540pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20388540pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20388540lld:pubmed